After 3 months ' treatment , the scores of patients ' symptoms and signs and serum IgE and IgG levels were significantly decreased in both muscular-injection and acupoint-injection groups ( P < 0.01 ) , while asthma controlled test ( ACT ) scores FEV 1/FVC % and PEF % values were considerably increased in both groups compared to pre-treatment in the same one group ( P < 0.01 ) .